LNWO vs LGND
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LNWO · Light & Wonder$75.57 ▼ 2.68%
LGND · Ligand Pharmaceuticals$286.85 ▼ 0.03%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LNWO -19.1%
- LGND +38.6%
Head to head
| Metric | LNWO | LGND |
|---|---|---|
| Price | $75.57 | $286.85 |
| Change today | ▼ 2.68% | ▼ 0.03% |
| Market cap | $5.74B | $5.74B |
| Return, 3 months | -17.7% | +2.4% |
| Return, year to date | -26.7% | +51.7% |
| Return, 1 year | -16.2% | +44.0% |
| P/E (TTM) | 20.0 | 115.2 |
| P/B | 13.6 | 6.0 |
| P/E percentile vs own 5y | – | 99th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -31.8% |
| Net profit growth (YoY) | – | -124.3% |
| Gross margin | – | 95.2% |
| Operating margin | – | 14.4% |
| Net margin | – | 20.3% |
| Return on equity | – | 5.4% |
| Analyst target vs. price | – | +27.9% |
| Analyst buy share | – | 100% |
| RSI (14) | 34 | 39 |
| 30-day volatility | 41.8% | 38.6% |
| Max drawdown, 1 year | -42.2% | -14.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LNWO is the largest of the group by market value.
- LGND has returned the most over the past year.
- LNWO carries the lowest trailing P/E.
- LGND has been the calmest stock over the last 30 days.